Day 1 (Monday, May 12th)
East Ballroom – Level 4
8:00 – 8:30 : Welcome and Breakfast8:30 – 9:00 : Welcome – Anick Bérard , University of Montreal, Principal Investigator CAMCCO (Research, Training, Outreach, Registry)
9:00 – 10:30 : 2024-2025 CAMCCO – Year in Review and Accomplishments
Cardiovascular diseases in pregnancy – Isabelle Malhamé , McGill University
Anti-seizure medication use during pregnancy and the risk of neurodevelopmental disorders –Odile Sheehy , CHU Sainte-Justine
Valproic acid-induced placental toxicity: investigating morphological and structural changes in CD-1 mice – Lauren Brown , Queen's University
Quantitative bias assessment in OTC pregnancy studies – Lisane Leal , CHU Sainte-Justine
Medication exposure definitions in perinatal pharmacoepidemiology: implications for pregnancy studies – Gabra Nohmie , University of Montreal
10:30 – 11:00 : Health BreakMark Walker , University of Ottawa
11:30 – 12:30 : CAMCCO-L Trainee Oral Presentations (2024-2025 Cohort)
Alaa Haboush , McGill University – Longitudinal Trajectories of Anti-Diabetic Medications from Pre-Conception to Delivery in UK Primary Care
Kevin Meesters , University of British Columbia – Burden and clinical characteristics of invasive meningococcal disease in Canada between 2012-2023: data from the Canadian Immunization Monitoring Program Active (IMPACT)
Diana Nelles , University of Toronto – The impact of interleukin (IL)-8 exposure on the expression of drug and folate transporters in human first trimester and term placental explants
Stephanie Skalitzky , University of Toronto – Vitamin D Dampens Toll-Like Receptor 7 (TLR-7)-mediated Inflammatory Response in a Pregnant Rat Model of Viral Infection
Perri Grant , Queen's University – Sex- and uterine horn-specific fetal liver cellular proliferation gene patterns after in utero benzene exposure in CD-1 mice
12:30 – 13:30 : Lunch
13:30 – 15:00 : Round Tables – Co-creation of 2 videos (FR and EN)
Moderators (person with lived experience): Kristi McIntosh, Laurie Proulx
From the lived experience to research objective
Consent in perinatal pharmacoepidemiology
15:00 – 16:00 : Health Break and Recordings of the CAMCCO Videos
16:00 – 17:30 : Machine Learning in Pregnancy (Masterclass) – Padma Kaul , University of Alberta
17:30 – 18:00 : CNPRM Opening Adress (
Ballroom – Level 4)18:30 – 21:00 : CAMCCO Team Dinner – Ferreira Café (1446 Peel Street, Montreal)
Day 2 (Tuesday, May 13th)
East Ballroom – Level 4
8:00 – 8:30 : Breakfast8:30 – 10:30 : Workshop – Emulating clinical trials in pregnancy using real-world data (RWD) (Bring your laptop ) – Sonia Grandi (University of Toronto) and Cristina Longo (Université de Montréal)
11:00 – 12:30 : Joint CNPRM-CAMCCO Plenary – Acetaminophen use during pregnancy and risk of neurodevelopmental disorders
Moderator: Tamil Kendall , Partnership for Women's Health Research Canada
Anick Bérard , University of Montreal – What is the evidence and how valid is it?
Louise Winn , Queen's University – Is there biological plausibility?
Diane Francoeur , University of Montreal and CEO of SOGC – Society of Obstetricians and Gynaecologists of Canada (SOGC) Guidelines
CAMCCO-L Trainee Oral Presentations (2024-2025 Cohort)
Marion Lecorguillé , McGill University – Perinatal Mental Health, Pharmacological Treatment, and Potential Influence on Child Development
Enav Zusman , University of British Columbia – Prenatal Serotonin Reuptake Inhibitor Antidepressant Exposure, Maternal Depression, and Cortisol Activity in 12-Year-Old Children: A Cohort Study
12:30 – 13:30 : Lunch
13:30 – 15:00 : Thematic session of your choice in the
CNPRM Program
15:00 – 15:30 : Health Break15:30 – 17:00 : Thematic session of your choice in the
CNPRM Program
17:00 – 19:00 : Joint Poster Session (CAMCCO, CNPRM, ENRICH)
19:00 – 20:00 : (Keynote) Health of Migrant Families – Cécile Rousseau , McGill University
20:00 – 21:00 : Dinner (CAMCCO, CNPRM, ENRICH)
.png)
.png)
.png)
%20(1).png)
666.png)
%20(Stroke).svg){kind=small}
.png)
.png)
